Literature DB >> 16317554

[Percutaneous large core breast biopsy].

K Prechtel1, J de Waal, A Nerlich, D Hölzel, J Weitz.   

Abstract

Percutaneous large core biopsy of the breast with a 14-gauge needle, supported by sonographic and mammographic procedures, shows a high degree of safety during the collection for benign and malignant lesions. All malignant diagnoses (B 5) with a portion of 44% (267/604) were confirmed surgically, whereby the typing with 79% and grading with 58% were congruent. In 3.3% (20/604), there was uncertainty (B 3 and B 4), with the necessity for further clarification by open biopsy. This was supported by the fact that in 10/16 operated cases carcinoma was found. In the B 2-category, with a portion of nearly 44% (264/604), four cases of cancer were verified--not due to a wrongly negative histology but to non-representative material. In 8.8% (53/604), a questionable representative histology (B 1) occurred, but no cancer was found after surgical intervention (n=7). The indication for surgery is not only the punch biopsy result, but additionally negative histology and suspect or malignant clinical findings.

Entities:  

Mesh:

Year:  2006        PMID: 16317554     DOI: 10.1007/s00292-005-0800-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  22 in total

1.  [Clinical experience with large-core needle biopsies of the breast and evaluation of histopathology].

Authors:  N Fersis; B Smyczek-Gargya; U Krainick; G Mielke; M Müller-Schimpfle; L Kiesel; D Wallwiener
Journal:  Zentralbl Gynakol       Date:  2001-03

2.  [Value of 14-gauge ultrasound-guided large-core needle biopsy of breast lesions: own results in comparison with the literature].

Authors:  M Memarsadeghi; G Pfarl; C Riedl; T Wagner; M Rudas; T H Helbich
Journal:  Rofo       Date:  2003-03

3.  [Sonographical breast biopsy: how many core biopsy specimens are needed?].

Authors:  R Schulz-Wendtland; U Aichinger; S Krämer; M Tartsch; I Kuchar; A Magener; W Bautz
Journal:  Rofo       Date:  2003-01

4.  Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate?

Authors:  P J Carder; J C Liston
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

5.  False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 concecutive cases of missed breast cancer.

Authors:  Varsha I Shah; Usha Raju; Dhananjay Chitale; Vikram Deshpande; Nancy Gregory; Vernon Strand
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

6.  Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation.

Authors:  Reshma Ariga; Kenneth Bloom; Vijaya B Reddy; Larry Kluskens; Darius Francescatti; Kambiz Dowlat; Popi Siziopikou; Paolo Gattuso
Journal:  Am J Surg       Date:  2002-11       Impact factor: 2.565

7.  Large-needle core biopsy: nonmalignant breast abnormalities evaluated with surgical excision or repeat core biopsy.

Authors:  J E Meyer; D N Smith; S C Lester; P J DiPiro; C M Denison; S C Harvey; R L Christian; A Richardson; W D Ko
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

8.  [Sonographically guided core needle biopsy of the breast: technique, accuracy and indications].

Authors:  W Buchberger; A Niehoff; P Obrist; G Rettl; M Dünser
Journal:  Radiologe       Date:  2002-01       Impact factor: 0.635

9.  Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3).

Authors:  A H S Lee; H E Denley; S E Pinder; I O Ellis; C W Elston; P Vujovic; R D Macmillan; A J Evans
Journal:  Histopathology       Date:  2003-04       Impact factor: 5.087

10.  Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme.

Authors:  J E Dahlstrom; S Jain; T Sutton; S Sutton
Journal:  Histopathology       Date:  1996-05       Impact factor: 5.087

View more
  1 in total

1.  Comparison of hormonal receptor and HER2 status between ultrasound-guided 14-gauge core needle biopsy and surgery in breast cancer patients.

Authors:  Yun Joo Park; Ji Hyun Youk; Eun Ju Son; Hye Mi Gweon; Jeong-Ah Kim
Journal:  Ultrasonography       Date:  2014-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.